NICE recommends first-in-class FRα ADC in platinum-resistant ovarian cancer
This is a further step towards biomarker-driven treatment in ovarian cancer. AbbVie recently announced that the National Institute for Health and...
Read More
This is a further step towards biomarker-driven treatment in ovarian cancer. AbbVie recently announced that the National Institute for Health and...
Read MoreWomen’s healthcare company, Organon, announced recently that the UK’s Medical Healthcare products Regulatory Agency (MHRA) has approved an extension of...
Read MoreCentral Medical Supplies (CMS), a provider of neonatal and patient warming solutions to UK healthcare providers, is proud to celebrate...
Read MoreScientists have developed a powerful new approach to detecting endometriosis - already attracting attention from leading pharmaceutical players - which is set...
Read MoreA doctor at Sheffield Teaching Hospitals NHS Foundation Trust has received a national award in recognition of her significant and lasting improvements to women’s...
Read MoreTen previously unknown symptoms may indicate an increased risk of severe seizures in pregnant women with preeclampsia - enabling timely...
Read MoreFindings offer reassurance to clinicians and pregnant women, say researchers A large South Korean study published by The BMJ recently...
Read MoreA Coventry mum has swapped the classroom for the delivery suite after her own maternity experiences inspired her to help...
Read MoreObs Gynae & Midwifery News (OGMN) is a leading trade title in the field of obstetrics, gynaecology, midwifery and women’s health
Having been at the forefront of this critical field for over a decade as its leading trade title, Obs Gynae & Midwifery News is now an exclusively digital platform.